988 related articles for article (PubMed ID: 16574264)
1. A low molecular weight fraction of polyethylenimine (PEI) displays increased transfection efficiency of DNA and siRNA in fresh or lyophilized complexes.
Werth S; Urban-Klein B; Dai L; Höbel S; Grzelinski M; Bakowsky U; Czubayko F; Aigner A
J Control Release; 2006 May; 112(2):257-70. PubMed ID: 16574264
[TBL] [Abstract][Full Text] [Related]
2. Polyethylenimine PEI F25-LMW allows the long-term storage of frozen complexes as fully active reagents in siRNA-mediated gene targeting and DNA delivery.
Höbel S; Prinz R; Malek A; Urban-Klein B; Sitterberg J; Bakowsky U; Czubayko F; Aigner A
Eur J Pharm Biopharm; 2008 Sep; 70(1):29-41. PubMed ID: 18499413
[TBL] [Abstract][Full Text] [Related]
3. Polyethylenimine/small interfering RNA-mediated knockdown of vascular endothelial growth factor in vivo exerts anti-tumor effects synergistically with Bevacizumab.
Höbel S; Koburger I; John M; Czubayko F; Hadwiger P; Vornlocher HP; Aigner A
J Gene Med; 2010 Mar; 12(3):287-300. PubMed ID: 20052738
[TBL] [Abstract][Full Text] [Related]
4. RNAi-mediated gene-targeting through systemic application of polyethylenimine (PEI)-complexed siRNA in vivo.
Urban-Klein B; Werth S; Abuharbeid S; Czubayko F; Aigner A
Gene Ther; 2005 Mar; 12(5):461-6. PubMed ID: 15616603
[TBL] [Abstract][Full Text] [Related]
5. Polyethylenimines for RNAi-mediated gene targeting in vivo and siRNA delivery to the lung.
Günther M; Lipka J; Malek A; Gutsch D; Kreyling W; Aigner A
Eur J Pharm Biopharm; 2011 Apr; 77(3):438-49. PubMed ID: 21093588
[TBL] [Abstract][Full Text] [Related]
6. In vivo pharmacokinetics, tissue distribution and underlying mechanisms of various PEI(-PEG)/siRNA complexes.
Malek A; Merkel O; Fink L; Czubayko F; Kissel T; Aigner A
Toxicol Appl Pharmacol; 2009 Apr; 236(1):97-108. PubMed ID: 19371615
[TBL] [Abstract][Full Text] [Related]
7. Liposome-polyethylenimine complexes for enhanced DNA and siRNA delivery.
Schäfer J; Höbel S; Bakowsky U; Aigner A
Biomaterials; 2010 Sep; 31(26):6892-900. PubMed ID: 20561681
[TBL] [Abstract][Full Text] [Related]
8. Polyethylenimine (PEI)/siRNA-mediated gene knockdown in vitro and in vivo.
Höbel S; Aigner A
Methods Mol Biol; 2010; 623():283-97. PubMed ID: 20217558
[TBL] [Abstract][Full Text] [Related]
9. Gene silencing through RNA interference (RNAi) in vivo: strategies based on the direct application of siRNAs.
Aigner A
J Biotechnol; 2006 Jun; 124(1):12-25. PubMed ID: 16413079
[TBL] [Abstract][Full Text] [Related]
10. PEG conjugated VEGF siRNA for anti-angiogenic gene therapy.
Kim SH; Jeong JH; Lee SH; Kim SW; Park TG
J Control Release; 2006 Nov; 116(2):123-9. PubMed ID: 16831481
[TBL] [Abstract][Full Text] [Related]
11. Target specific tumor treatment by VEGF siRNA complexed with reducible polyethyleneimine-hyaluronic acid conjugate.
Park K; Lee MY; Kim KS; Hahn SK
Biomaterials; 2010 Jul; 31(19):5258-65. PubMed ID: 20378167
[TBL] [Abstract][Full Text] [Related]
12. The induction of tumor apoptosis in B16 melanoma following STAT3 siRNA delivery with a lipid-substituted polyethylenimine.
Alshamsan A; Hamdy S; Samuel J; El-Kadi AO; Lavasanifar A; Uludağ H
Biomaterials; 2010 Feb; 31(6):1420-8. PubMed ID: 19913908
[TBL] [Abstract][Full Text] [Related]
13. Effective polyethylenimine-mediated gene transfer into human endothelial cells.
Zaric V; Weltin D; Erbacher P; Remy JS; Behr JP; Stephan D
J Gene Med; 2004 Feb; 6(2):176-84. PubMed ID: 14978771
[TBL] [Abstract][Full Text] [Related]
14. Effect of homobifunctional crosslinkers on nucleic acids delivery ability of PEI nanoparticles.
Swami A; Goyal R; Tripathi SK; Singh N; Katiyar N; Mishra AK; Gupta KC
Int J Pharm; 2009 Jun; 374(1-2):125-38. PubMed ID: 19446769
[TBL] [Abstract][Full Text] [Related]
15. A unique and highly efficient non-viral DNA/siRNA delivery system based on PEI-bisepoxide nanoparticles.
Swami A; Kurupati RK; Pathak A; Singh Y; Kumar P; Gupta KC
Biochem Biophys Res Commun; 2007 Nov; 362(4):835-41. PubMed ID: 17822674
[TBL] [Abstract][Full Text] [Related]
16. Degradable polyethylenimines as DNA and small interfering RNA carriers.
Jere D; Jiang HL; Arote R; Kim YK; Choi YJ; Cho MH; Akaike T; Cho CS
Expert Opin Drug Deliv; 2009 Aug; 6(8):827-34. PubMed ID: 19558333
[TBL] [Abstract][Full Text] [Related]
17. Prostate cancer cell-specific VEGF siRNA delivery system using cell targeting peptide conjugated polyplexes.
Kim SH; Lee SH; Tian H; Chen X; Park TG
J Drug Target; 2009 May; 17(4):311-7. PubMed ID: 19242850
[TBL] [Abstract][Full Text] [Related]
18. Novel shielded transferrin-polyethylene glycol-polyethylenimine/DNA complexes for systemic tumor-targeted gene transfer.
Kursa M; Walker GF; Roessler V; Ogris M; Roedl W; Kircheis R; Wagner E
Bioconjug Chem; 2003; 14(1):222-31. PubMed ID: 12526712
[TBL] [Abstract][Full Text] [Related]
19. N-Succinyl-chitosan grafted with low molecular weight polyethylenimine as a serum-resistant gene vector.
Lu B; Sun YX; Li YQ; Zhang XZ; Zhuo RX
Mol Biosyst; 2009 Jun; 5(6):629-37. PubMed ID: 19462020
[TBL] [Abstract][Full Text] [Related]
20. Controlled cytoplasmic and nuclear localization of plasmid DNA and siRNA by differentially tailored polyethylenimine.
Shim MS; Kwon YJ
J Control Release; 2009 Feb; 133(3):206-13. PubMed ID: 18992289
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
